Broker tips: AstraZeneca, GlaxoSmithKline, Shire, Pets at Home
22nd Apr 2014 12:53
Societe Generale has kept a 'sell' recommendation on AstraZeneca (AZN), questioning the reasoning behind a potential takeover by US pharmaceutical peer Pfizer. Societe said: "In our view, given AZN's forecast revenue and earnings profile through 2018-2019 (an earnings decline until 2018), which is
Read moreLondon midday: Pharma deals lift stocks as FTSE 100 nears 6,700
22nd Apr 2014 11:36
- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,741.04 +2.28% FTSE 100 6,691.88 +1.01% FTSE 250 16,103.19 +1.23% Heightened M&A activity in the pharmaceutical sector gave UK markets a boost on Tues
Read moreRose-tinted glasses needed to acquire AstraZeneca, says Societe
22nd Apr 2014 10:41
Societe Generale has kept a 'sell' recommendation on AstraZeneca (AZN), questioning the reasoning behind a potential takeover by US pharmaceutical peer Pfizer. Nevertheless, while the recent speculation "may be unfounded in reality", M&A chatter may help to support the shares in the short term, Soc
Read morePfizer likely to make second approach for AstraZeneca, says Citi
22nd Apr 2014 09:51
Shares in AstraZeneca (AZN) were rising strongly on Tuesday morning in London on the back of speculation that US pharmaceutical peer Pfizer could make a 60bn-pound takeover bid for the British-Swedish company. The rumours, first reported by The Sunday Times, said that the two parties had held infor
Read moreLondon open: Pharma M&A gives UK stocks a lift
22nd Apr 2014 08:59
- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,729.51 +1.85% FTSE 100 6,683.16 +0.87% FTSE 250 16,031.64 +0.78% Strong gains from heavyweight pharmaceutical groups gave UK markets a boost on Tuesd
Read moreTuesday newspaper round-up: AstraZeneca, Ukraine, Energy companies
22nd Apr 2014 07:10
AstraZeneca has recruited the services of two Wall Street heavyweights to fend off any possible further takeover attempt by US rival Pfizer. The American company, for its part, has hired JP Morgan to advise it on a possible purchase. Shares of Pfizer actually gained on the news although default swap
Read moreAstraZeneca jumps in US trading on Pfizer takeover speculation - UPDATE
22nd Apr 2014 06:07
US shares of AstraZeneca surged in New York on Monday on speculation that the company could be at the centre of the largest pharmaceutical takeover in history. The Sunday Times said informal talks between AstraZeneca and Pfizer had taken place in recent weeks, which saw the US pharma giant make a t
Read moreSunday newspaper round-up: AstraZeneca, Ukraine, Tax cuts
20th Apr 2014 19:53
In recent weeks, Pfizer has held informal conversations with British rival AstraZeneca about a possible takeover by the US drugs giant, according to senior investment bankers and industry sources. With 50,000 employees worldwide the UK outfit, Britain's tenth largest company, might be valued at over
Read moreTuesday broker round-up UPDATE
1st Apr 2014 09:39
African Barrick Gold: Deutsche Bank raises target price from 240p to 310p and keeps a hold recommendation. African Minerals: Deutsche Bank lowers target price from 399p to 382p, while its buy recommendation is kept. Allergy Therapeutics: Panmure Gordon ups target price from 16p to 25p and retains
Read moreCarnival Chairman reduces stake by around a quarter
26th Mar 2014 15:54
Micky Arison, the long-standing Chairman of cruise line operator Carnival Corp., docked a batch of shares earlier this week ahead of its better-than-expected first quarter trading update. Arison offloaded 525,348 at $40.09 each, reducing his stake to 104.52m shares. The group on Tuesday reported
Read moreAstraZeneca brings on board Mastercard executive
20th Mar 2014 11:15
Pharmaceutical group AstraZeneca has announced that the President of Master Card's International Markets division, Ann Cairns, will be proposed to shareholders for election as a non-executive director. The board has also suggested appointing Cairns to the group's audit committee at upon her electio
Read moreEx-Asos man Williams dips in on arrival at Rightmove
19th Mar 2014 15:57
Peter Williams, a new non-executive director at property website Rightmove, has made a significant statement about his confidence in the company with a 99,463 pounds purchase of shares just over a month after his appointment. Williams filled a similar independent role at online retailer Asos for ei
Read moreJP Morgan says sell AstraZeneca
14th Mar 2014 14:58
Investors in AstraZeneca have been waiting seven years for the company's 15.6bn dollar purchase of US outfit Medimmune in 2007 to pan out and they may have longer to wait. Some things may just not be worth waiting for, as JP Morgan explained to clients, according to the Financial Times. Shares
Read moreLondon midday: Stocks extend losses ahead of Crimea referendum
14th Mar 2014 11:38
- Ukraine tensions rise ahead of Crimea vote - Analysts cut forecasts for China - Banking stocks mixed - US lifts ban on BP GoM contracts techMARK 2,765.64 -0.76% FTSE 100 6,529.08 -0.38% FTSE 250 16,062.45 -0.76% The FTSE 100 was registering losses for the sixth consecutive session as investors s
Read moreLondon open: Stocks down for sixth day on Ukraine, China fears
14th Mar 2014 08:32
- Ukraine crisis steps up a gear - Analysts cut forecasts for China - US lifts ban on BP GoM contracts - Financials gain, miners fall techMARK 2,757.98 -1.04% FTSE 100 6,525.28 -0.43% FTSE 250 16,032.04 -0.95% UK stocks were suffering losses again on Friday, falling for the sixth straight day, as
Read more